BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30

Benzinga · 2d ago
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $29 to $30.